Physician

Obstetrics & Gynecology

Dr. Charles W. Drescher practices Obstetrics & Gynecology. He went to University of Michigan Medical School. He has 2 awards "Regional Top Doctor" and "Super Doctor". Charles Drescher is a published doctor as well. He has 36 publications published. The latest was: Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors. He accepts all Medicare patients.

Publications

---

• Targeted single molecule mutation detection With massively parallel sequencing.
• Identifying post-menopausal women at elevated risk for epithelial ovarian Cancer.
• Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian Carcinoma and benign serous ovarian tumors.
• Ultrasound Molecular Imaging in a Human CD276 Expression-Modulated Murine Ovarian Cancer Model.
• Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer.
• Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule.
• Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling.
• Involvement in decision-making about treatment and ovarian Cancer survivor quality of life.
• Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer.
• An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.
• ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma.
• Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal Status.
• Early diagnosis of ovarian Carcinoma: is a solution in sight?
• Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases.
• Use of a Symptom Index, CA125, and HE4 to predict ovarian Cancer.
• Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian Cancer: evidence supporting a mesothelial-to-epithelial transition.
• DNA methylation profiles of ovarian epithelial Carcinoma tumors and cell lines.
• Quantitative proteomics analysis integrated With microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chem...
• Influence of ovarian cancer risk Status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.
• Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal Carcinoma with the potential for dose escala...
• Repertoire of microRNAs in epithelial ovarian Cancer as determined by next generation sequencing of small RNA cDNA libraries.
• Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy PostMenopausal women at high-risk for ovarian cancer.
• Circulating microRNAs as stable blood-based markers for Cancer detection.
• Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial Cancer staging.
• Proteomic analysis of ovarian Cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.
• Systematic evaluation of candidate blood markers for detecting ovarian Cancer.
• Development of an ovarian Cancer symptom index: possibilities for earlier detection.
• Clear cell adenoCarcinoma of the vagina in a patient with vaginal endometriosis.
• Bead-based ELISA for validation of ovarian Cancer early detection markers.
• Proteins associated with Cisplatin resistance in ovarian Cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.
• Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian Cancer.
• Compliance of average- and intermediate-risk women to semiannual ovarian Cancer screening.
• Adequate staging for uterine Cancer can be performed through Pfannenstiel incisions.
• Three-consecutive-day topotecan is an active regimen for recurrent epithelial ovarian Cancer.
• Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial Carcinoma.

Schools

---

• University Of Michigan Medical School

• University of Washington

• University Of Michigan

Procedures Preformed

---

• Abdominal Hysterectomy With Robotic Assistance
• C-Section
• Colpopexy
• Colpopexy With Robotic Assistance
• View All

Conditions Treated

---

• Asymptomatic Post-Menopausal Status
• Carcinoma in Situ
• Cervical Cancer
• Cervical Polyps
• View All

Doctors Specialties

---

• Gynecologic Oncology
• Obstetrics
• Gynecology

Accepted Insurances

---

Awards

---

• Regional Top Doctor
• Super Doctor

Education

---

• University of Michigan Hospitals and Health Centers
• University of Washington
• University of Michigan Medical School

Hospital

---

• Swedish Medical Center-Cherry Hill Campus
• Overlake Medical Center
• EvergreenHealth

Drug Facts

---

NPI NUMBER		1710939855
NPPES Provider LastName		DRESCHER
NPPES Provider FirstName		CHARLES
NPPES Provider ZIPCode		981041306
NPPES Provider State		WA
Specialty Description		Gynecological/Oncology
Total Claim Count		201.0
Distinct Opioid Count		2.0
Opioid Claim Count		25.0
Percent Opioid Claims		12.44

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1710939855
Last Name Of The Provider	DRESCHER
First Name Of The Provider	CHARLES
View All

Similar Doctors

---

	Dr. Elise N. Everett, MD This Doctor is OpenDoctor Recommended.
	Dr. Dionne R. Gallagher, MD This Doctor is OpenDoctor Recommended.
	Dr. Ann M. Kolwitz, MD This Doctor is OpenDoctor Recommended.
	Dr. Carolyn R. Kline, MD This Doctor is OpenDoctor Recommended.
	Dr. Harold L. Zimmer, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel Gavrila, MD This Doctor is OpenDoctor Recommended.
	Dr. Peter D. Wall, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael M. Lawler, MD This Doctor is OpenDoctor Recommended.
	Dr. Vivienne L. Souter, MD This Doctor is OpenDoctor Recommended.
	Dr. Elisabeth S. Anton, MD This Doctor is OpenDoctor Recommended.
	Dr. Khurram S. Rehman, MD This Doctor is OpenDoctor Recommended.
	Dr. Jonathan I. Paley, MD This Doctor is OpenDoctor Recommended.
	Dr. Desiree L. Otto, MD This Doctor is OpenDoctor Recommended.
	Dr. Pamela J. Paley, MD This Doctor is OpenDoctor Recommended.
	Dr. Danica M. Bloomquist, MD This Doctor is OpenDoctor Recommended.
	Dr. Judith A. Lacy, MD This Doctor is OpenDoctor Recommended.
	Dr. Nancy M. Tipton, MD This Doctor is OpenDoctor Recommended.
	Dr. Karen J. Hamilton, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan B. Storck, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog